Measures involving in vitro assay                


Select table page: First Prev 1 - 10 / 20 (20) Next Last
    Access protocols via the Procedure column.
Sort/
Pick
Data set
Procedure / Protocol
Treatment
Phenotype Measure / Variable (click to view)
Panel
No. of Strains
Sex
Age
Sample Size (Avg)
Year
    Cowell1 in vitro assay Staphylococcus aureus log10 bacterial colony count from peritoneal fluid 24h post-infection (x 103) (CFU/mL)   [log(n/mL)]  peritoneal_CFU   49002 inbred 13 f 8wks N=5 2012
    Cowell1 in vitro assay Staphylococcus aureus log10 bacterial colony count from kidney 24h post-infection (CFU/g)   [log(n/g)]  kidney_CFU   49003 inbred 13 f 8wks N=6 2012
    CSNA03 in vitro assay (none) peak-to-peak interval, indicating amount of time it takes for one cycle of bioluminescence circadian rhythm, in fibroblast cultures, founders   [h]  period_in   112539     inbred w/CC8 8 both 8-12wks N=9 2020
    CSNA03 in vitro assay (none) peak-to-peak interval, indicating amount of time it takes for one cycle of bioluminescence circadian rhythm, in fibroblast cultures, CC   [h]  period_cc   112544     CC w/par 40 both 8-12wks N=4 2020
    CSNA03 in vitro assay (none) specific time point when bioluminescence reaches highest circadian rhythm amplitude (cycle number), in fibroblast cultures, founders   [n]  phase_in   112540     inbred w/CC8 8 both 8-12wks N=9 2020
    CSNA03 in vitro assay (none) specific time point when bioluminescence reaches highest circadian rhythm amplitude (cycle number), in fibroblast cultures, CC   [n]  phase_cc   112545     CC w/par 40 both 8-12wks N=4 2020
    CSNA03 in vitro assay (none) peak-to-trough, indicating level of synchronization in circadian rhythm (max counts/s), in fibroblast cultures, founders   [n/s]  amplitude_in   112541     inbred w/CC8 8 both 8-12wks N=9 2020
    CSNA03 in vitro assay (none) peak-to-trough, indicating level of synchronization in circadian rhythm (max counts/s), in fibroblast cultures, CC   [n/s]  amplitude_cc   112546     CC w/par 40 both 8-12wks N=4 2020
    CSNA03 in vitro assay (none) number of days required for circadian rhythm amplitude to decrease to 36% of initial value, in fibroblast cultures, founders   [days]  damping_in   112542     inbred w/CC8 8 both 8-12wks N=9 2020
    CSNA03 in vitro assay (none) number of days required for circadian rhythm amplitude to decrease to 36% of initial value, in fibroblast cultures, CC   [days]  damping_cc   112547     CC w/par 40 both 8-12wks N=4 2020
    All boxes             To see more rows use the paging control at top.


  •   Or, add these measures to your collection.
       
  •     no folder
  •     put them in new folder